Reduction of Sleep Medications via a Combined Digital Insomnia and Pharmacist-Led Deprescribing Intervention: Protocol for a Feasibility Trial (Preprint)
Authors:
- Adam D BramowethABAdam D Bramoweth
- Caroline E HoughCHCaroline E Hough
- Amanda D McQuillanAMAmanda D McQuillan
- Brittany L SpitznogleBSBrittany L Spitznogle
- Carolyn T ThorpeCTCarolyn T Thorpe
- James J LickelJLJames J Lickel
- Monique Boudreaux-KellyMonique Boudreaux-Kelly
- Megan E HammMHMegan E Hamm
- Anne GermainAGAnne Germain
Preprint
- 3 May 2023
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Chronic insomnia is one of the most common health problems among veterans and negatively impacts their health, function, and quality of life. Although cognitive behavioral therapy for insomnia (CBT-I) is the first-line recommended treatment, sedative-hypnotic medications remain the most common. Sedative-hypnotics, however, have mixed effectiveness, are frequently prescribed longer than recommended, and are associated with numerous risks and adverse effects that negatively impact veteran function. Meeting the treatment needs of veterans impacted by insomnia requires delivering gold standard behavioral care, like CBT-I, and the reduction of sedative-hypnotics through innovative methods. OBJECTIVE The objective of this feasibility clinical trial is to test a digital CBT-I approach combined with deprescribing to improve the success of sedative-hypnotic reduction among veterans. The intervention combines Noctem Health Clinician Operated Assistive Sleep Technology (COAST), an effective and efficient, scalable, and adaptable digital platform to deliver CBT-I, with clinical pharmacy practitioner (CPP)–led deprescribing of sedative-hypnotic medications. METHODS In this nonrandomized single-group clinical trial, 50 veterans will be recruited and enrolled to receive CBT-I delivered via Noctem COAST and CPP-led deprescribing for up to 12 weeks. Assessments will occur at baseline, posttreatment, and 3-month follow-up. The aims are to (1) assess the feasibility of recruiting veterans with chronic sedative-hypnotic use to participate in the combined intervention, (2) evaluate veterans’ acceptability and usability of the COAST platform, and (3) measure changes in veterans’ sleep, sedative-hypnotic use, and function at baseline, posttreatment, and 3-month follow-up. RESULTS The institutional review board approved the study in October 2021 and the trial was initiated in May 2022. Recruitment and data collection began in September 2022 and is anticipated to be completed in April 2024. Aim 1 will be measured by tracking the response to a mail-centric recruitment approach using electronic medical records to identify potentially eligible veterans based on sedative-hypnotic use. Aim 2 will be measured using the Post-Study System Usability Questionnaire, assessing overall usability as well as system usefulness, information quality, and interface quality. Aim 3 will use the Insomnia Severity Index and sleep diaries to measure change in insomnia outcomes, the Patient-Reported Outcome Measurement Information System Profile to measure change in physical function, anxiety, depression, fatigue, sleep disturbance, participation in social roles, pain, cognitive function, and self-reported sedative-hypnotic use to measure change in dose and frequency of use. CONCLUSIONS Findings will inform the utility of a combined digital CBT-I and CPP-led deprescribing intervention and the development of an adequately powered clinical trial to test the effectiveness in a diverse sample of veterans. Further, findings will help inform potential new approaches to deliver care and improve access to care for veterans with insomnia, many of whom use sedative-hypnotics that may be ineffective and increase the risk for negative outcomes. CLINICALTRIAL ClinicalTrials.gov NCT05027438; https://classic.clinicaltrials.gov/ct2/show/NCT05027438 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/47636Keywords
All Related Versions
- Published version: JMIR Research Protocols, 12 (1), e47636.
This publication has 56 references indexed in Scilit:
- Sleep Disturbance Preceding Suicide Among VeteransAmerican Journal of Public Health, 2012
- The Consensus Sleep Diary: Standardizing Prospective Sleep Self-MonitoringSLEEP, 2012
- Sedative Medication Use: Prevalence, Risk Factors, and Associations with Body Mass Index Using Population-Level DataSLEEP, 2011
- “… Not Just a Minor Thing, It Is Something Major, Which Stops You From Functioning Daily”: Quality of Life and Daytime Functioning in InsomniaBehavioral Sleep Medicine, 2010
- Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent InsomniaJAMA, 2009
- Effectiveness and cost-effectiveness of an educational intervention for practice teams to deliver problem focused therapy for insomnia: rationale and design of a pilot cluster randomised trialBMC Family Practice, 2009
- Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disordersClinical Psychology Review, 2005
- Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria – a population‐based cohort studyBritish Journal of Clinical Pharmacology, 2005
- Cognitive-behavioral treatment of insomnia secondary to chronic pain.Journal of Consulting and Clinical Psychology, 2000
- IBM computer usability satisfaction questionnaires: Psychometric evaluation and instructions for useInternational Journal of Human–Computer Interaction, 1995